Lactose, Sucrose & Corn Syrup Tolerance

NCT ID: NCT01789307

Last Updated: 2014-07-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Lactose, one of the key nutrients in human milk may be critically important to infants for more reasons than being a source of energy. We are interested in understanding how lactose when compared to other sugars influences how nutrients, specifically macronutrients are handled after digestion and absorption. To date, there have been no studies looking at how fat and protein varies when lactose compared to other sugars is ingested. There may be metabolic advantages to considering lactose for nutrition support of premature infants rather than glucose or dextrose as is often used in intravenous feeds, or the corn syrup solids in lactose-free formulas. We hope the information from this study will provide new information on the unique aspects of lactose.

Hypothesis: The hypothesis is that providing carbohydrate as lactose:

1. minimizes the amount of carbohydrate that is converted into fat
2. enables a relatively constant metabolic state throughout feeding interval that avoids swings of high to low insulin, glucose, and fats.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Focus of Study: Oral Tolerance Test With Glucose, Lactose, Sucrose

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

corn syrup solids

corn syrup solids oral ingestion

Group Type ACTIVE_COMPARATOR

corn syrup solids

Intervention Type DIETARY_SUPPLEMENT

oral ingestion 50 grams, 2 doses

sucrose

sucrose oral ingestion

Group Type EXPERIMENTAL

sucrose

Intervention Type DIETARY_SUPPLEMENT

oral ingestion 50 grams, 2 doses

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

corn syrup solids

oral ingestion 50 grams, 2 doses

Intervention Type DIETARY_SUPPLEMENT

sucrose

oral ingestion 50 grams, 2 doses

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

corn syrup

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male
* at least 19 years of age
* body mass index (BMI) between 18.5 and 25
* fasting blood glucose level \< 6.1 mmol/L (110 mg/dL) measured by glucometer on the day of the study and
* comfortable speaking, reading and understanding English
* comfortable drinking at least one cup (250 ml) of milk
* non-smoking

Exclusion Criteria

* not willing to provide blood samples, have
* impaired lactose or glucose tolerance,
* pre-diabetes, diabetes mellitus and any other endocrine disorder,
* coronary heart disease, liver function test abnormalities or any chronic disease
* routinely take medications, including aspirin, cyclooxygenase-2 inhibitors, statins and fish oil
* consuming more than 1 alcoholic drink per day
Minimum Eligible Age

19 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of British Columbia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sheila M Innis, PhD

Role: PRINCIPAL_INVESTIGATOR

University of British Columbia, Child & Family Research Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Child & Family Research Institute

Vancouver, British Columbia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H12-01647

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Milk for Diabetes Prevention
NCT06513026 NOT_YET_RECRUITING NA